Cargando…
Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017
BACKGROUND: Direct oral anticoagulants (DOACs), namely rivaroxaban, apixaban, dabigatran, and edoxaban, are now included together with warfarin as standards of care for the primary treatment of venous thromboembolism (VTE). The extent to which the DOACs have been adopted since receiving US Food and...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6782014/ https://www.ncbi.nlm.nih.gov/pubmed/31624786 http://dx.doi.org/10.1002/rth2.12222 |